Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.87
+0.57 (6.87%)
At close: Apr 28, 2026, 4:00 PM EDT
8.91
+0.04 (0.45%)
After-hours: Apr 28, 2026, 6:46 PM EDT
ARCT Employees
As of December 31, 2025, Arcturus Therapeutics Holdings had 111 total employees, including 106 full-time and 5 part-time employees. The number of employees decreased by 65 or -36.93% compared to the previous year.
Employees
111
Change (1Y)
-65
Growth (1Y)
-36.93%
Revenue / Employee
$739,018
Profits / Employee
-$592,640
Market Cap
252.11M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Voyager Therapeutics | 141 |
| Adagene | 128 |
| Heron Therapeutics | 128 |
| Orchestra BioMed Holdings | 86 |
| SAB Biotherapeutics | 86 |
| Camp4 Therapeutics | 48 |
| Milestone Pharmaceuticals | 38 |
ARCT News
- 1 day ago - Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026 - Business Wire
- 5 weeks ago - Arcturus Therapeutics Holdings Transcript: The 38th Annual Roth Conference - Transcripts
- 6 weeks ago - Arcturus Therapeutics Holdings Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Arcturus Therapeutics to Attend Upcoming Investor Conference - Business Wire
- 2 months ago - Arcturus Therapeutics Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress - Business Wire
- 2 months ago - Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026 - Business Wire
- 2 months ago - Arcturus Therapeutics Holdings Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts